Andy Gesek

Andy Gesek has over 20 years of work experience in the pharmaceutical industry. In 1997, they began their career at Novartis as Manager of Field Force Analysis & New Initiatives. Andy then moved to Pharmacia in 1999, where they served as Senior Manager of North America Business Analysis. In 2001, they joined British Technology Group, Intl. as Associate Vice President of Financial Analysis & Valuation. In 2005, they founded and became General Manager of Pounce Sports, LLC. In 2006, they joined Wyeth Pharmaceuticals as Executive Director of Global Forecasting. In 2009, they joined Endo Pharmaceuticals as Vice President of Business Operations & Planning and Senior Director of Business Strategy & New Product Planning. In 2015, they became Managing Partner of Fort Washington Pharma. In 2016, they became President of Timm Medical Technologies. In 2022, they joined Neuraptive Therapeutics as Commercial Business and BD and Executive Partner with Salt Creek Capital.

Andy Gesek obtained a BS in Accounting & Finance from Drexel University's LeBow College of Business between 1988 and 1993. Andy then went on to obtain an MBA from The Wharton School between 1999 and 2001. Andy also holds an MBA certification.